NCT06770842
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Department of Medicine, Queen Mary Hospital Hong Kong
Clinical trial condition
Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
Explore clinical trials studying Post Essential Thrombocythaemia Myelofibrosis (PET-MF). Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Post Essential Thrombocythaemia Myelofibrosis (PET-MF) trial results
NCT01558739
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
- Locations
-
- Novartis Investigative Site Cardiff, Wales, United Kingdom
- Novartis Investigative Site Bournemouth, United Kingdom
- Novartis Investigative Site East Yorkshire, United Kingdom
- Novartis Investigative Site Edinburgh, United Kingdom